IOVANCE BIOTHERAPEUTICS INC (IOVA)
US4622601007 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -410.00M | -444.04M | -395.89M | -342.25M | -259.58M | |||
| Depreciation Amortization | 31.51M | 21.42M | 9.31M | 3.11M | 1.14M | |||
| Change In Working Capital | -78.83M | -10.00M | -2.89M | 24.55M | 2.98M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 6.15M | 3.48M | N/A | N/A | N/A | |||
| Other non cash items | 93.67M | 70.80M | 96.72M | 86.65M | 50.32M | |||
| OPERATING CASH FLOW | -363.65M | -361.82M | -292.76M | -227.94M | -205.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -10.43M | -22.29M | -20.43M | -37.57M | -46.79M | |||
| Other Investing Activity | -182.50M | -132.95M | 276.88M | 37.71M | -271.06M | |||
| INVESTING CASH FLOW | -192.93M | -155.24M | 256.46M | 130.00K | -317.85M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 1.00M | N/A | |||
| Stock Issued/Repurchased | 401.48M | 465.75M | 192.80M | 238.27M | 576.71M | |||
| Other Financing Activity | -12.16M | -2.79M | -2.65M | N/A | -280.00K | |||
| FINANCING CASH FLOW | 389.31M | 462.96M | 190.15M | 239.27M | 576.42M | |||
| Exchange Rate Effect | 3.66M | -2.74M | N/A | N/A | N/A | |||
| CHANGE IN CASH | -163.61M | -56.84M | 153.85M | 11.46M | 53.44M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -363.65M | -361.82M | -292.76M | -227.94M | -205.13M | |||
| Capital Expenditure | -10.43M | -22.29M | -20.43M | -37.57M | -46.79M | |||
| FREE CASH FLOW | -374.08M | -384.11M | -313.19M | -265.51M | -251.92M | |||
All data in USD